Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/17049Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hurley, Jeremiah E. | en_US |
| dc.contributor.author | Johnson, Nancy A. (Nancy Arbuthnot) | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.coverage.spatial | Canada | en_US |
| dc.date.accessioned | 2015-04-14T14:41:59Z | - |
| dc.date.available | 2015-04-14T14:41:59Z | - |
| dc.date.issued | 1991 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/17049 | - |
| dc.description | Jeremiah Hurley, Nancy Arbuthnot Johnson. | en_US |
| dc.description | Bibliography: leaves 26-29. | en_US |
| dc.format.extent | 29 leaves. | en_US |
| dc.publisher | McMaster University | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 91-1 | en_US |
| dc.subject | Economics, Medical | en_US |
| dc.subject | Nonprescription Drugs | en_US |
| dc.subject | Prescription Fees | en_US |
| dc.subject | Insurance, Pharmaceutical Services | en_US |
| dc.subject | Prescription Drugs | en_US |
| dc.subject | economics | en_US |
| dc.subject | Drug Costs | en_US |
| dc.title | effects of co-payments in the prescription drug market | en_US |
| dc.type | text | en_US |
| Appears in Collections: | CHEPA Working Paper Series | |
Files in This Item:
There are no files associated with this item.
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.
